Thomas Martin Schmeing
0000-0002-8061-0436
1 paper found
Refreshing results…
A second-generation eIF4A RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer
Missing publications? Search for publications with a matching author name.